Morse Barnes Brown and Pendleton
Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Thursday, November 20, 2008

Former Stryker sales rep. found to plead guilty

By Mass High Tech Staff

A former sales representative for a Hopkinton medical device manufacturer, found to be Stryker Biotech, has pleaded guilty to charges that he falsified documentation for medical devices he was selling, according to published reports.

The Boston Business Journal uncovered the identity of Stryker, which had not been named fully in court. The sales rep, Darnell Martin, of Chicago, provided written instructions for using the medical devices in a manner not sanctioned by the U.S. Food and Drug Administration, the Boston Business Journal reported.

Sentencing is scheduled for May 13, 2009. If convicted, Martin could spend eight years in prison and pay $260,000 in fines, the report adds.

Stryker Biotech is part of Stryker Corp. in Kalamazoo, Mich.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Comments

Please Login/Register to post comments.

No comments have been added or approved.

On the MHT blog now

Flagsuit wins another NASA Astronaut Glove Challenge

Southwest Harbor, Maine's Peter Homer won $450,000 in NASA's Astronaut Glove Challenge yesterday. This is Homer's second time winning the contest. Homer's first win in 2007 launched his startup, Flagsuit. Flagsuit is developing pressure suits using the same technology as Homer's prizewinning gloves -- for use as a wearable substitute for hyperbaric chambers used to treat conditions such as ...

Read More

Most Popular Stories
EmailedViewed
Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
FinanceFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of, registration on, this site constitutes acceptance of our User Agreement. Please read our Privacy Policy (updated) A publishing partner with Portfolio